Last deal

$3.08M

Amount

Venture - Series Unknown

Stage

07.05.2015

Date

3

all rounds

$63.19M

Total amount

date founded

Financing round

General

About Company
Theraclone Sciences develops innovative therapeutic antibodies for infectious diseases and inflammation.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Spaltudaq

founded date

01.01.2004

founders

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

Theraclone Sciences, a Seattle-based biotech company, focuses on discovering and developing novel therapeutic antibodies to treat infectious diseases and inflammation. Their technology taps into the human immune system to identify naturally evolved monoclonal antibodies from immunologically relevant individuals. By leveraging their discovery platform, they can rapidly obtain recombinant human monoclonal antibodies for large-scale production. These antibody candidates have the potential to combat diseases and be administered to a wide patient population. Theraclone is privately funded by ARCH Venture Partners, Canaan Partners, Healthcare Ventures, Amgen Ventures, MPM Capital, and Alexandria Real Estate Investment. Their comprehensive approach allows medical practitioners to screen and identify rare disease-fighting antibodies produced by selected individuals.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
VBL THERAPEUTICS

VBL THERAPEUTICS

VBL Therapeutics is a clinical stage biotech company that develops innovative treatments for cancer and immune-inflammatory diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Or Yehuda, Israel

total rounds

6

total raised

$58.72M
Vaccinex

Vaccinex

Vaccinex develops targeted biotherapeutics for cancer, neurodegenerative diseases, and autoimmune disorders.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Rochester, NY, USA

total rounds

12

total raised

$80.7M
AIMM Therapeutics

AIMM Therapeutics

AIMM Therapeutics produces monoclonal antibodies by immortalising B cells from elite patients.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Amsterdam, Netherlands

total rounds

1
Cincera Therapeutics

Cincera Therapeutics

Cincera Therapeutics is a biotechnology company developing drugs to treat metabolic diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Biopharma

Location

Dandenong Rd, Melbourne VIC, Australia

total rounds

3

total raised

$6.17M

Financials

Funding Rounds
8
3

Number of Funding Rounds

$63.19M

Money Raised

Their latest funding was raised on 07.05.2015. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
07.05.2015
$3.08M
25.03.2013
8
$8M
25.03.2013
2
$6M
Zenyaku Kogyo

Zenyaku Kogyo

Zenyaku Kogyo is a pharmaceutical company focused on developing and marketing dermatological and anti-cancer drugs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Keywords

Pharmaceuticals, Health Care, Biotechnology

Location

Tokyo, Japan

count Of Investments

5
Co-Investors
Investors
11
2

Number of lead investors

11

Number of investors

Investor 
Lead 
Round 
Partners 
Institute for Systems Biology

Institute for Systems Biology

Institute for Systems Biology develops cures and treatments for diseases and environmental issues through systems biology.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Non-Profit, Financial Services

Location

Seattle, WA, USA

total rounds

1

total raised

$13M

count Of Investments

3
Alexandria Real Estate Equities

Alexandria Real Estate Equities

Alexandria Real Estate Equities, Inc. is the largest and leading provider of real estate to the life science industry.

Sector

Real Estate Investment Trusts

Subsector

Real Estate Investment Trusts

Keywords

Real Estate, Real Estate Investment

Location

Pasadena, CA, USA

total rounds

3

total raised

$700.22M

count Of Investments

36

count Of Exists

8
Canaan Partners

Canaan Partners

Canaan Partners is an early stage venture capital firm.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Menlo Park, CA, USA

count Of Investments

623

count Of Exists

138
Wende Hutton

Wende Hutton

current job

Canaan Partners
Canaan Partners

count Of Investments

1

People

Founders
1
Johnny Stine
Johnny Stine

Johnny Stine

Developer of discovery platforms designed to find rare, disease-fighting antibodies possessing characteristics for therapeutic or diagnostic applications using a unifying concept of efficient host immune repertoire sampling of mother nature's vastly complex pool of antibodies and their natural heavy and light chain pairs. Validation of this concept is seen in the results of my founding of Theraclone-Sciences (fka Spaltudaq) which has two antibodies in clinical trials, a four target deal with Pfizer, flu collaboration with Zinyaku Kogyo, an impressive HIV relationship with IAVI, and is now going to be publicly traded; the founding of North Coast and V-Gene, Inc. where corporate relationships have led to antibody clinical lead candidates.

organization founded

1

Johnny Stine

Employee Profiles
13

Rebecca Sherpa

Research assistant ii

Eleanor L. Ramos

Chief Medical Officer

Steven Gillis

Steven Gillis

Acting President

Activity

Recent News
0